Home
Service
Humanized model of the immune system
iHuPBMC-T
iHuPBMC-NK
iHuPBMC-B
PBMC-LT
CD34+ HSC
Winn model
iHuPBMC-MHC/KO
iHuPBMC-OncVax
PBMC mixed inoculation model
In vivo tumor experimental platform
CDX
iHuPDX
Non-GLP Toxicology
PK/PD
Brain in situ model
Other in situ models
Hematologic tumor model system inoculation
Creation of high interstitial tumor models
In vitro killing experiment platform
Immune co-culture killing model
CDC
IC50
PDC High-Throughput In Vitro Pharmacodynamics
3D organoids
ADCC
T cell-mediated killing experiment
Mouse-derived immune system model
Homogeneous Model
SCID mouse NK efficacy model
Homologous Models in Genetic Engineering
Tumor vaccine
PBMC-OncVax tumor vaccine model
MHC humanized mouse model
Cell therapy
Car-T
Car-T-MHC/KO
Car-NK
Host anti-graft reaction (HVG)
In vitro testing platform
ELISpot
ELISA
FACS
Luminex
qPCR
Non-GLP Toxicology Platform
GVHD experimental platform
Immunogenicity testing
Non-tumor model and drug efficacy evaluation platform
Systematic Vaccination Model
Model
PDX model
Head and neck cancer
Eye cancer
Lung cancer
Human breast cancer
Esophageal cancer in humans
Human gastric cancer
Colorectal cancer
Human liver cancer
Bile duct cancer
Gallbladder cancer
Human pancreatic cancer
Human kidney cancer
Human Bladder Cancer
Ureteral cancer
Prostate cancer
Uterine cancer
Cervical cancer in women
Human Ovarian Cancer
Human skin cancer
sarcoma
Human Nervous System Cancer
Embryonal carcinoma
Human Lymphoma
Human leukemia
Multiple Myeloma
Adrenal gland
Mesothelioma
Other people
CDX model
Breast cancer
Stomach cancer
Liver cancer
Pancreatic cancer
Kidney cancer
Bladder cancer
Cervical cancer
Ovarian cancer
Esophageal cancer
Skin cancer
Nervous System Cancer
Lymphoma
Leukemia
Other
Databases
About Us
Company Profile
Team Introduction
History
Recruiting Talents
Contact Us
Research findings
News
Company News
Industry news
Cn /En
model
Syngenic model